|
PKD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66058999999663E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.981100E-04 |
| Normal-vs-Stage2 |
2.627600E-02 |
| Normal-vs-Stage3 |
4.703800E-01 |
| Normal-vs-Stage4 |
2.163400E-01 |
| Stage1-vs-Stage2 |
9.640600E-01 |
| Stage1-vs-Stage3 |
7.203700E-02 |
| Stage1-vs-Stage4 |
1.538220E-03 |
| Stage2-vs-Stage3 |
1.739630E-01 |
| Stage2-vs-Stage4 |
2.245600E-02 |
| Stage3-vs-Stage4 |
2.430400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.21169999999882E-05 |
| Normal-vs-AfricanAmerican |
4.338300E-03 |
| Normal-vs-Asian |
8.987600E-02 |
| Caucasian-vs-AfricanAmerican |
3.949400E-01 |
| Caucasian-vs-Asian |
8.346000E-02 |
| AfricanAmerican-vs-Asian |
3.848200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.93640000000417E-05 |
| Normal-vs-Female |
3.236100E-03 |
| Male-vs-Female |
6.970400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.461620E-01 |
| Normal-vs-Extreme_Weight |
8.406500E-04 |
| Normal-vs-Obese |
2.235500E-03 |
| Normal-vs-Extreme_Obese |
3.989800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.818600E-01 |
| Normal_Weight-vs-Obese |
3.630600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.670000E-01 |
| Extreme_Weight-vs-Obese |
8.258200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.660000E-01 |
| Obese-vs-Extreme_Obese |
6.056400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.396200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.12299999999832E-05 |
| Normal-vs-Age(61-80Yrs) |
2.662200E-03 |
| Normal-vs-Age(81-100Yrs) |
5.900300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.462600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.054800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.645200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.058400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.377200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.158200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.89769999714429E-08 |
| Normal-VS-Type2 PRCC |
6.156800E-01 |
| Normal-VS-KIRP CIMP |
3.627400E-01 |
| Normal-VS-Unclassified PRCC |
3.516000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.0966000004512E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.156820E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.275000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.885200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.642900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.202200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.203000E-01 |
| Normal-vs-N1 |
6.833200E-01 |
| Normal-vs-N2 |
5.488200E-01 |
| N0-vs-N1 |
2.650600E-01 |
| N0-vs-N2 |
4.298800E-01 |
| N1-vs-N2 |
8.104000E-01 |
|
|
